Eventide Asset Management »

Sionna Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $26M 639k 41.14

More positions owned by Eventide Asset Management

Guardant Health (GH)
Xometry Class A Com (XMTR)
Mirum Pharmaceuticals (MIRM)
Trane Technologies SHS (TT)
Beta Bionics (BBNX)
Irhythm Technologies (IRTC)
Ge Vernova (GEV)
Lam Research Corp Com New (LRCX)
Scholar Rock Hldg Corp (SRRK)
Axsome Therapeutics (AXSM)
Argenx Se Sponsored Adr (ARGX)
Old Dominion Freight Line (ODFL)
Targa Res Corp (TRGP)
Toast Cl A (TOST)
Collegium Pharmaceutical Inc Common Stock Usd (COLL)

View all positions for Eventide Asset Management

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Atlas Venture Life Science Advisors
Viking Global Investors
Enavate Sciences GP
Jpmorgan Chase & Co
Vanguard Group
Perceptive Advisors
Jennison Associates
Deerfield Management Company
BlackRock
Standard Life Aberdeen
State Street Corporation
Eventide Asset Management

View all funds holding Sionna Therapeutics